Publication:
Role of Subconjunctival Bevacizumab as an Adjuvant to Primary Trabeculectomy: A Prospective Randomized Comparative 1-Year Follow-up Study

dc.contributor.authorAkkan, JÜLİDE CANAN
dc.contributor.authorCILSIM, Semih
dc.contributor.institutionauthorUMURHAN AKKAN, JÜLİDE CANAN
dc.date.accessioned2019-10-05T21:55:16Z
dc.date.available2019-10-05T21:55:16Z
dc.date.issued2015-01-01
dc.description.abstractPurpose: To compare the safety and efficacy of primary trabeculectomy with adjunctive subconjunctival bevacizumab with that of primary trabeculectomy with mitomycin C (MMC).
dc.identifier10.3109/01902148.2012.689088
dc.identifier.citationAkkan J. C. , CILSIM S., -Role of Subconjunctival Bevacizumab as an Adjuvant to Primary Trabeculectomy: A Prospective Randomized Comparative 1-Year Follow-up Study-, JOURNAL OF GLAUCOMA, cilt.24, ss.1-8, 2015
dc.identifier.doi10.1097/ijg.0b013e318287abf3
dc.identifier.scopus84924922021
dc.identifier.urihttps://hdl.handle.net/20.500.12645/8451
dc.identifier.wosWOS:000346844000001
dc.language.isoen
dc.titleRole of Subconjunctival Bevacizumab as an Adjuvant to Primary Trabeculectomy: A Prospective Randomized Comparative 1-Year Follow-up Study
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameExperimental lung research
local.avesis.idd2a5636a-c720-496a-904f-0e1cfeab3a6d
local.avesis.response8327
local.publication.isinternational1
relation.isAuthorOfPublication0ac69bf6-a1a3-4a8b-be3a-ee84839bbc03
relation.isAuthorOfPublication.latestForDiscovery0ac69bf6-a1a3-4a8b-be3a-ee84839bbc03
Files